EIT Health Catapult Finalists 2020

Zoan BioMed is delighted to announce it was successful in today’s semi final of the EIT Health Catapult Programme – earning its place in the final later this year. The line up of 40 semi finalists across MedTech, BioTech and Digital Health represent some of the most exciting innovations in healthcare across Europe today. Zoan BioMed’s achievement of its place in the final is further demonstration of its continued path towards commercialisation in 2021. We look forward to the next opportunity to showcase the opportunities that our platform offers.

We would like to thank EIT for its continued support and mentorship and look forward to our future collaborations together.

The finals take place in December and you can register to attend the finals as part of EIT’s Health Summit here.

EIT Health is supported by the European Institute of Innovation and Technology, a body of the European Union, to find out more visit https://eithealth.eu/

Latest News

Northwell Health USA and Portershed Galway Visit Zoan

We were delighted to have the opportunity to host, Mary Rodgers (CEO, PorterShed Galway) ,
Kevin Beiner (Senior Vice President and Regional Executive Director, Northwell Health) Elaine
Brennan (Executive Director & Chief Commercialization Officer at Northwell Health) Jennifer
Scanlon (AVP Strategic Partnerships at Northwell Health) to our facility last week.

KPMG Global Tech Innovator Finalist

Dublin, June 2022 Zoan Biomed was chosen as one of the finalists in the KPMG Global Tech Innovator series. With 70+ impressive entrants representing the very best innovations in Ireland, the 8 finalists got to present to some of Ireland’s leading business personalities.
The Zoan Biomed innovation was lauded for its uniqueness, impact to industry and sustainability credentials.

Zoan BioMed & CELLINK Sign Co-Development Partnership

Dublin, Boston, Gothenburg – April, 2022—Imagine a future where a bone break can be repaired by 3D-printing bones made from marine coral. That reality may come a lot sooner that one might think, thanks to a truly innovative collaboration agreement between Irish-owned, and Galway-based, Zoan BioMed, and Sweden-based CELLINK (STO: BICO). Uniquely, Zoan BioMed sustainably grows…

Zoan Biomed Partnership with the European Maritime Fisheries Fund

In 2019 we launched our partnership with the European Maritime and Fisheries Fund of the European Union, CORAL4HEALTH. A 2-year engagement that initiated with high expectations and acknowledgment of the considerable innovation challenges that lay ahead. The overall aim of the CORAL4HEALTH project was to commercialise the next generation graft bone substitutes, drawn from a…

Contact Us

To find out more about Zoan BioMed get in touch